The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 2,080,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
| ACELYRIN INC | COM | 00445A100 | 9,335,744 | 1,893,660 | SH | SOLE | 1,893,660 | 0 | 0 | |||
| ADAGIO MED HLDGS INC | COM | 00534B100 | 285,273 | 110,571 | SH | SOLE | 110,571 | 0 | 0 | |||
| AEROVATE THERAPEUTICS INC | COM | 008064107 | 919,600 | 440,000 | SH | SOLE | 440,000 | 0 | 0 | |||
| ALLAKOS INC | COM | 01671P100 | 1,572,644 | 2,407,600 | SH | SOLE | 2,407,600 | 0 | 0 | |||
| APPLIED THERAPEUTICS INC' | COM | 03828A101 | 11,220,000 | 1,320,000 | SH | SOLE | 1,320,000 | 0 | 0 | |||
| ARVINAS INC | COM | 04335A105 | 30,910,650 | 1,255,000 | SH | SOLE | 1,255,000 | 0 | 0 | |||
| BIODESIX INC | COM | 09075X108 | 6,970,700 | 3,815,000 | SH | SOLE | 3,815,000 | 0 | 0 | |||
| CARGO THERAPEUTICS INC | COM | 14179K101 | 11,834,513 | 541,437 | SH | SOLE | 541,437 | 0 | 0 | |||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 2,236,500 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | |||
| CODEXIS INC | COM | 192005106 | 27,011,600 | 8,770,000 | SH | SOLE | 8,770,000 | 0 | 0 | |||
| CYTOKINETICS INC | COM NEW | 23282W605 | 3,975,840 | 75,300 | SH | SOLE | 75,300 | 0 | 0 | |||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 13,945,525 | 522,500 | SH | SOLE | 522,500 | 0 | 0 | |||
| ETON PHARMACEUTICALS INC | COM | 29772L108 | 16,680,000 | 2,780,000 | SH | SOLE | 2,780,000 | 0 | 0 | |||
| GINKGO BIOWORKS HOLDINGS | Class A New | 37611X209 | 6,684,646 | 820,202 | SH | SOLE | 820,202 | 0 | 0 | |||
| GOSSAMER BIO INC | COM | 38341P102 | 3,705,692 | 3,665,010 | SH | SOLE | 3,665,010 | 0 | 0 | |||
| GOSSAMER BIO INC | NOTE 5.000% 6/0 | 38341PAA0 | 4,188,928 | 8,000,000 | PRN | SOLE | 8,000,000 | 0 | 0 | |||
| HARROW HEALTH INC | COM | 415858109 | 179,390,400 | 3,990,000 | SH | SOLE | 3,990,000 | 0 | 0 | |||
| IBIO INC | COM NEW | 451033708 | 832,500 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
| IMMUNOME INC | COM | 45257U108 | 18,092,250 | 1,237,500 | SH | SOLE | 1,237,500 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 6,649,335 | 353,500 | SH | SOLE | 353,500 | 0 | 0 | |||
| KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 3,960,672 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | |||
| KEROS THERAPEUTICS INC | COM | 492327101 | 22,953,677 | 395,276 | SH | SOLE | 395,276 | 0 | 0 | |||
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 16,981,420 | 1,698,142 | SH | SOLE | 1,698,142 | 0 | 0 | |||
| LYELL IMMUNOPHARMA INC | COM | 55083R104 | 1,925,100 | 1,395,000 | SH | SOLE | 1,395,000 | 0 | 0 | |||
| NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 5,561,000 | 335,000 | SH | SOLE | 335,000 | 0 | 0 | |||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 9,437,400 | 420,000 | SH | SOLE | 420,000 | 0 | 0 | |||
| NUVALENT INC | COM | 670703107 | 6,547,200 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | |||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 43,717,500 | 5,025,000 | SH | SOLE | 5,025,000 | 0 | 0 | |||
| PEPGEN INC | COM | 713317105 | 1,532,331 | 179,200 | SH | SOLE | 179,200 | 0 | 0 | |||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 4,725,000 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | |||
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | 3,076,512 | 1,681,154 | SH | SOLE | 1,681,154 | 0 | 0 | |||
| REGULUS THERAPEUTICS INC | COM | 75915K309 | 839,950 | 535,000 | SH | SOLE | 535,000 | 0 | 0 | |||
| RELMADA THERAPEUTICS INC | COM | 75955J402 | 1,555,200 | 480,000 | SH | SOLE | 480,000 | 0 | 0 | |||
| REVANCE THERAPEUTICS INC | COM | 761330109 | 1,427,250 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | |||
| REZOLUTE INC | COM NEW | 76200L309 | 2,262,831 | 466,563 | SH | SOLE | 466,563 | 0 | 0 | |||
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 26,195,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
| SYROS PHARMACEUTICALS INC | COM NEW | 87184Q206 | 1,408,127 | 654,943 | SH | SOLE | 654,943 | 0 | 0 | |||
| TG THERAPEUTICS INC | COM | 88322Q108 | 53,329,200 | 2,280,000 | SH | SOLE | 2,280,000 | 0 | 0 | |||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 8,577,087 | 2,567,990 | SH | SOLE | 2,567,990 | 0 | 0 | |||
| UROGEN PHARMA LTD | COM | M96088105 | 5,132,070 | 404,100 | SH | SOLE | 404,100 | 0 | 0 | |||
| VAXCYTE INC | COM | 92243G108 | 9,712,950 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | |||
| XOMA CORP DEL | COM NEW | 98419J206 | 6,620,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | 3,558,560 | 967,000 | SH | SOLE | 967,000 | 0 | 0 | |||